Larimar Therapeutics Inc. buy Global_Player
Start price
24.03.25
/
50%
€2.18
Target price
24.03.26
-
Performance (%)
-9.63%
End price
29.03.25
€1.97
Summary
This prediction ended on 29.03.25 with a price of €1.97. With a performance of -9.63%, the BUY prediction by Global_Player finished with a loss. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Larimar Therapeutics Inc. | -5.581% | -5.581% | 150.617% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
According to Global_Player what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Zafgen Inc. diskutieren
Buy Larimar Therapeutics Inc.
In the thread Trading Zafgen Inc.
Stopped prediction by Global_Player for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.50
28.09.25
28.09.25
-
28.09.26
28.09.26
-20.89%
01.10.25
01.10.25
Could be worthwhile Investment >10% per year
